NeoGenomics
NEO
$15.13
Share price
-2.83%
Change (1 day)
-1.75%
Change (1 year)
Market capitalization of NeoGenomics (NEO)
Market cap: $1.93 Billion
As of May 2024 NeoGenomics has a market cap of $1.93 Billion. This makes NeoGenomics the world's 4182th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of NeoGenomics from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.93 B | -6.31% |
| 2023 | $2.06 B | 76.72% |
| 2022 | $1.16 B | -72.22% |
| 2021 | $4.20 B | -29.72% |
| 2020 | $5.97 B | 95.04% |
| 2019 | $3.06 B | 157.29% |
| 2018 | $1.19 B | 67.2% |
| 2017 | $0.71 B | 5.88% |
| 2016 | $0.67 B | 12.76% |
| 2015 | $0.59 B | 137.53% |
| 2014 | $0.25 B | 41.28% |
| 2013 | $0.17 B | 58.34% |
| 2012 | $0.11 B | 85.52% |
| 2011 | $60.53 M | 24.42% |
| 2010 | $48.65 M | -12.78% |
| 2009 | $55.77 M | 188.34% |
| 2008 | $19.34 M | -42.94% |
| 2007 | $33.9 M | -16.48% |
| 2006 | $40.59 M | 835.52% |
| 2005 | $4.33 M | -19.42% |
| 2004 | $5.38 M | 483.74% |
| 2003 | $0.92 M | -74.27% |
| 2002 | $3.58 M | -40.97% |
| 2001 | $6.07 M |
End of Day market cap according to different sources
On May 8th, 2024 the market cap of NeoGenomics was reported to be:
$1.93 Billion
$1.93 Billion
$1.93 Billion
$1.93 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | $15.12 B | 682.70% | 🇺🇸 USA |
 LabCorp LH | $16.99 B | 779.50% | 🇺🇸 USA |
 RadNet RDNT | $3.74 B | 93.62% | 🇺🇸 USA |
 Psychemedics PMD | $14.74 M | -99.24% | 🇺🇸 USA |
 Enzo Biochem ENZ | $57.37 M | -97.03% | 🇺🇸 USA |